tiprankstipranks
Trending News
More News >

Mark Christopher Capone Insider Profile

4 Followers
Mark Christopher Capone, President & C.E.O. at Myriad Genetics, holds 2.13K shares in Mesa Laboratories (Ticker: MLAB), holds 82.05K shares in DermTech (Ticker: DMTKQ), holds 522.22K shares in Myriad Genetics (Ticker: MYGN).
tipranks
Mark Christopher Capone

Mark Christopher Capone
Myriad Genetics (MYGN)
President & C.E.O.

Ranked #16,414 out of 104,104 Corporate Insiders

Profitable Transactions

80%
4 out of 5 Profitable Transactions

Average Return

+22.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$4M
95.11%
4.89%
A breakdown of Mark Christopher Capone's holdings

Insider Roles

Myriad Genetics
(MYGN)
President & C.E.O.
Mesa Laboratories
(MLAB)
Director
Roles that Mark Christopher Capone holds in companies

Most Profitable Insider Trade

Stock:
Myriad Genetics
(MYGN)
Rating:Informative Sell
Date:Jul 13, 2018 - Jul 13, 2019
Return:+39.70%
The most profitable trade made by Mark Christopher Capone

Mark Christopher Capone's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Myriad Genetics
Oct 01, 2019
President & C.E.O.
Uninformative Sell
773.64K
$3.38M
DMTKQ
DermTech
Jun 05, 2023
Uninformative Buy
$1.64K
Mesa Laboratories
Aug 18, 2025
Director
Uninformative Buy
96.69K
$174.13K
List of latest transactions for each holding click on a transaction to see Mark Christopher Capone's performance on stock

Mark Christopher Capone insider profile FAQ

What is the percentage of profitable transactions made by Mark Christopher Capone?
The percentage of profitable transactions made by Mark Christopher Capone is 80%.
    What is the average return per transaction made by Mark Christopher Capone?
    The average return per transaction made by Mark Christopher Capone is 22.90%.
      What stocks does Mark Christopher Capone hold?
      Mark Christopher Capone holds: MYGN, DMTKQ, MLAB stocks.
        What was Mark Christopher Capone’s latest transaction?
        Mark Christopher Capone latest transaction was an Uninformative Buy of $96.69K.
          What was Mark Christopher Capone's most profitable transaction?
          Mark Christopher Capone’s most profitable transaction was an Informative Sell of MYGN stock on July 13, 2018. The return on the trade was 39.70%.
            What is Mark Christopher Capone's role in Myriad Genetics?
            Mark Christopher Capone's role in Myriad Genetics is President & C.E.O..
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.